These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23128250)

  • 41. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
    Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
    Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
    Luczak MW; Jagodzinski PP
    Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.
    Tan CL; Teissier S; Gunaratne J; Quek LS; Bellanger S
    Cell Cycle; 2015; 14(9):1459-70. PubMed ID: 25789401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of HPV16 E6/7 on the expression of FGF2 and FGFR type B in cervical carcinogenesis.
    Cheng YM; Chou CY; Hsu YC; Chen MJ
    Reprod Sci; 2012 Jun; 19(6):580-6. PubMed ID: 22421447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of siRNA inhibiting HPV16 E6 gene expression on proliferation and cell cycle of cervical cancer cell line CaSki].
    Guan LL; Peng ZL; Niu XY; Wang HJ; Wang DQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):10-4. PubMed ID: 18390189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.
    Iancu IV; Pleşa A; Botezatu A; Huică I; Stănescu AD; Socolov D; Anton G
    Roum Arch Microbiol Immunol; 2015; 74(1-2):33-9. PubMed ID: 26727852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.
    Weijzen S; Zlobin A; Braid M; Miele L; Kast WM
    J Cell Physiol; 2003 Mar; 194(3):356-62. PubMed ID: 12548555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer.
    Richard C; Lanner C; Naryzhny SN; Sherman L; Lee H; Lambert PF; Zehbe I
    Oncogene; 2010 Jun; 29(23):3435-45. PubMed ID: 20383192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of human papillomavirus 16 E6 and E7 oncogene on the proliferation and differentiation of human laryngeal squamous cell carcinoma cell line].
    Cai P; Wu ZY; Li JR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Oct; 42(10):774-8. PubMed ID: 18229591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
    Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A role for HPV16 E5 in cervical carcinogenesis.
    Maufort JP; Shai A; Pitot HC; Lambert PF
    Cancer Res; 2010 Apr; 70(7):2924-31. PubMed ID: 20332225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus type 16 E5 protein as a therapeutic target.
    Kim SW; Yang JS
    Yonsei Med J; 2006 Feb; 47(1):1-14. PubMed ID: 16502480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism.
    Zeng Q; Chen J; Li Y; Werle KD; Zhao RX; Quan CS; Wang YS; Zhai YX; Wang JW; Youssef M; Cui R; Liang J; Genovese N; Chow LT; Li YL; Xu ZX
    Oncogene; 2017 Mar; 36(9):1245-1255. PubMed ID: 27546620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
    Chen B; Zhao L; Yang R; Xu T
    Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promoting Vaginal Distribution of E7 and MCL-1 siRNA-Silencing Nanoparticles for Cervical Cancer Treatment.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Piel G; Hubert P
    Mol Pharm; 2017 May; 14(5):1706-1717. PubMed ID: 28350964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HPV16 activates the promoter of Oct4 gene by sequestering HDAC1 from repressor complex to target it to proteasomal degradation.
    Liu D; Zhou P; Zhang L; Zheng Y; He F
    Med Hypotheses; 2012 Oct; 79(4):531-4. PubMed ID: 22867868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mechanisms of high-risk human papillomavirus-induced cervical carcinogenesis].
    Narisawa-Saito M; Kiyono T
    Nihon Rinsho; 2009 Jan; 67(1):53-61. PubMed ID: 19177752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein.
    Lee SA; Ho C; Troxler M; Lin CY; Chung SH
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33800513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.